Sotatercept administration in a young infant with severe pulmonary arterial hypertension: A case report
Abstract
Idiopathic pulmonary arterial hypertension (PAH) in infants is a rare, life-threatening condition characterized by elevated pulmonary artery pressure resulting from endothelial dysfunction, vasoconstriction, and vascular remodeling. The treatment options are limited, and the prognosis is poor. In children, 5-year survival following diagnosis remains suboptimal, with estimates of approximately 74% despite advances in therapy. Unfortunately, many patients continue to experience clinical decline despite optimized medical regimens, highlighting the need for novel therapeutic approaches. Sotatercept, an activin receptor type IIB fusion protein, is a new therapeutic agent that modulates the signaling pathway of the transforming growth factor-beta superfamily. It enhances bone morphogenetic protein receptor type 2 signaling, thereby improving pulmonary vascular remodeling and promoting vasodilation. In adult clinical trials, sotatercept has demonstrated improvements in pulmonary vascular resistance, functional capacity, and biomarkers such as brain natriuretic peptide, while reducing the risk of clinical worsening or death, and it was recently approved by the FDA for use in adults to improve exercise capacity and the World Health Organization (WHO) functional class. Despite promising results in adults, data on the use of sotatercept in pediatric patients remain extremely limited and nonexistent for children <1 year of age. Herein, we report the first known use of sotatercept in an…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Protective effects of tadalafil and N-acetyl cysteine therapy on cisplatin-induced testicular toxicity
- The Use of Generative AI for Scientific Literature Searches for Systematic Reviews: ChatGPT and Microsoft Bing AI Performance Evaluation
- Sildenafil as a Candidate Drug for Alzheimer’s Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons
- Ozone-modified properties of pumpkin seed oil as anti-H. pylori, anticancer, anti-diabetic and anti-obesity agent
- Effectiveness of Low-Intensity Extracorporeal Shock Wave Therapy in Erectile Dysfunction: An Analysis of Sexual Function and Penile Hardness at Erection: An Umbrella Review
- Molecular Docking of Silymarin as a Ligand for Aromatase Enzyme and HIV-1 Reverse Transcriptase Using Molegro Virtual Docker
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.